All news

Obsidian Therapeutics, Inc. Initial Statement of Beneficial Ownership

Alpha Vantage · Stock Titan · · AI-summarised by FinFlash

This article announces the initial statement of beneficial ownership (Form 3) filed by Mark L. Reisenauer for Obsidian Therapeutics, Inc. (OBX) on November 13, 2026. Reisenauer is listed as a director and reported no beneficial ownership of non-derivative or derivative securities. The filing emphasizes transparency regarding insider relationships and beneficial ownership.

Read original source

OBX company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.